Abstract:Extract Optimal characterisation of early structural abnormalities has been highlighted as critical to future efforts to detect and prevent cystic fibrosis (CF) lung disease progression [1]. Computed tomography (CT) is currently the gold standard, detecting structural disease at an earlier stage than radiography or lung function testing, with predictive value for subsequent progression and later forced expiratory volume in 1 s (FEV 1 ) decline [1]. Compared to other emerging radiological modalities for early disease detection, such as magnetic resonance imaging (MRI), CT is more widely accessible and MRI at present is not able to directly quantify the extent of bronchiectasis due to its limitations in spatial resolution. Current US CF Foundation clinical guidelines state that CT should be "considered every 2–3 years, using the lowest possible radiation dose" [2]. Early lung disease is identified on CT by air trapping, increase in airway wall thickness and airway diameter, and potentially irreversible bronchiectasis [3]. Spirometer-directed CT has standardised lung volume acquisition and outlined the importance of both inspiratory and expiratory image acquisition [4]. Consensus recommendations for "low dose" CT scanning were published in 2016 [5], but radiation exposure remains a concern, given the six-fold increase in CT use and ongoing increase in cumulative radiation exposure for CF patients [6]. Imaging requires optimal structural information at the lowest possible radiation dose [5]. Given the increased vulnerability of children to ionising radiation, "low dose" CT protocols have already been incorporated in paediatric clinical trials using CT-based primary outcome measures [7], and use of ultra-low dose (ULD) CT has emerged in adult CF research and in isolated paediatric patients [6]. However, formal validation of the effects on quantitative measures of structural disease has not been performed. Low dose (LD) CT shows limitations compared to standard dose CT because of known drifts in CT lung density dependent on dose [8]. We hypothesised that ULD implementation would not detrimentally affect structural disease detection in early CF lung disease, and specifically targeted an age range to explore this where volume variation during spirometry-directed CT could be minimised between imaging modalities. Thus, the primary aims in this study were to 1) implement spirometer-directed novel ULD CT in school-aged children with CF, and 2) validate its outcomes against same-session LD CT using visual as well as fully automated quantitative CT analysis for structural airway disease.

Accuracy of Ultralow-Dose Photon-counting CT in the Detection of Lung Changes after Lung Transplant

Low-dose high-resolution chest CT in adults with cystic fibrosis: intraindividual comparison between photon-counting and energy-integrating detector CT

Photon Counting Computed Tomography with the Radiation Dose of a Chest X-Ray: Feasibility and Diagnostic Yield

Investigating the Small Pixel Effect in Ultra-High Resolution Photon-Counting CT of the Lung

Diagnostic Accuracy in Detecting Fungal Infection with Ultra-Low-Dose Computed Tomography (ULD-CT) Using Filtered Back Projection (FBP) Technique in Immunocompromised Patients

Low-Dose High-Resolution Photon-Counting CT of the Lung: Radiation Dose and Image Quality in the Clinical Routine

Detection and size quantification of pulmonary nodules in ultralow-dose versus regular-dose CT: a comparative study in COPD patients

Detection of Pulmonary Nodules on Ultra-low Dose Chest Computed Tomography With Deep-learning Image Reconstruction Algorithm

Lung Cancer in Lung Transplant Recipients: Clinical, Radiologic, and Pathologic Characteristics and Treatment Outcome

Advanced lung imaging with photon-counting detectors: Insights from thermoluminescence dosimetry

Ultra-high resolution spectral photon-counting CT outperforms dual layer CT for lung imaging: Results of a phantom study

Implementation and evaluation of ultra-low dose CT in early cystic fibrosis lung disease

Evaluating Lung Changes in Long COVID: Ultra-Low-Dose vs. Standard-Dose CT Chest

Detection and Size Measurements of Pulmonary Nodules in Ultra-Low-dose CT with Iterative Reconstruction Compared to Low Dose CT.

Ultra-low-dose vs. standard-of-care-dose CT of the chest in patients with post-COVID-19 conditions—a prospective intra-patient multi-reader study

Pulmonary nodule visualization and evaluation of AI-based detection at various ultra-low-dose levels using photon-counting detector CT

Screening for Lung Cancer Using Sub-Millisievert Chest CT with Iterative Reconstruction Algorithm: Image Quality and Nodule Detectability.

Ultra-low-dose CT Reconstructed with ASiR-V Using SmartmA for Pulmonary Nodule Detection and Lung-RADS Classifications Compared with Low-Dose CT

A new era of high-resolution CT diagnostics of the lung: improved image quality, detailed morphology, and reduced radiation dose with high-resolution photon-counting CT of the lungs compared to high-resolution energy-integrated CT

Optimizing lung biopsy procedures: Comparative analysis of diagnostic efficacy and safety in experimental low-dose, conventional low-dose, and standard-dose CT-guided approaches

A cost-free approach to evaluating vertebral body bone density and height loss in lung transplant recipients using routine chest CT